OVERVIEW

The demand for medical simulation is expected to hit USD 2,856.4 million by 2024, increasing over the forecast period at a CAGR of 14.45%. The benefits of simulation over traditional learning, increased demand for minimally invasive treatments, and increased focus on patient safety are the key factors driving the growth of the market's significant growth drivers.

TABLE OF CONTENT

1 Global Healthcare / Medical Simulation Market

• 1.1 Study Objectives
• 1.2 Market Definition
• 1.3 Study Scope
  • 1.3.1 Markets Covered
  • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Healthcare / Medical Simulation Market – Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Healthcare / Medical Simulation Market – Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Healthcare / Medical Simulation Market – Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis – Top 10 companies

• 6 Global Healthcare / Medical Simulation Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
      • 6.2.1.1 Advantage of simulation over traditional learning
      • 6.2.1.2 Rising demand for minimally invasive treatments
      • 6.2.1.3 Increasing focus on patient safety
    • 6.2.2 Challenges
      • 6.2.2.1 High cost of simulators
      • 6.2.2.2 Operational challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Healthcare / Medical Simulation Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Healthcare / Medical Simulation Market – By Product & Service (Market Size – &million/billion)
  • 8.1 Anatomical Models
  • 8.2 Web-Based Simulation
  • 8.3 Medical Simulation Software
  • 8.4 Simulation Training Services

• 9 Global Healthcare / Medical Simulation Market - By End-User
  • 9.1 Academic Institutes
  • 9.2 Hospitals
  • 9.3 Military Organizations
  • 9.4 Other

• 10 Global Healthcare / Medical Simulation Market – By Geography (Market Size – &million/billion)
  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 U.K
    • 10.3.2 Germany
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 South Korea
    • 10.4.5 Rest of APAC
  • 10.5 Rest of the World
    • 10.5.1 South America
    • 10.5.2 Middle East
    • 10.5.3 Africa

• 11 Global Healthcare / Medical Simulation Market – Entropy
  • 11.1 New product launches
  • 11.2 M&A's, collaborations, JVs and partnerships

• 12 Global Healthcare / Medical Simulation Market Company Profile (Key Players)
  • 12.1 Market Share, Company Revenue, Products, M&A, Developments
  • 12.2 CAE Inc.
  • 12.3 Laerdal Medical
  • 12.4 3D Systems
  • 12.5 Gaumard Scientific Company
  • 12.6 Limbs & Things
  • 12.7 Medaphor
  • 12.8 Mentice
  • 12.9 Simulaids
  • 12.10 Kyoto Kagaku
  • 12.11 Simulab
  • 12.12 Company 11 & more

• 13 Global Healthcare / Medical Simulation Market - Appendix
  • 13.1 Sources
  • 13.2 Abbreviations